Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
about
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseA new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseasesLow-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.Voltage-Gated Proton Channels as Novel Drug Targets: From NADPH Oxidase Regulation to Sperm BiologyA Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injuryNADPH oxidases: novel therapeutic targets for neurodegenerative diseasesDextromethorphan inhibits activations and functions in dendritic cells.Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis.Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease.Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules.Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.Chondroprotective Effects and Mechanisms of Dextromethorphan: Repurposing Antitussive Medication for Osteoarthritis Treatment.Dextromethorphan Attenuates NADPH Oxidase-Regulated Glycogen Synthase Kinase 3β and NF-κB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.
P2860
Q26748711-A6898344-581A-427E-8C90-BA4BEB834268Q27005806-CEC2138B-415D-4F42-8C6A-86893AF8204BQ34035333-E602DBCD-4054-4CED-B38A-DD2EFD7DD49FQ35977268-4B393A94-5F7B-4E6A-B7FC-A0F5F120ABDCQ36291166-E237874C-8968-4326-9B60-9E459D1BE646Q36336772-37BCA616-0AA9-4F88-9E39-C14E13D43020Q36921495-A1BA8543-4B05-426A-A983-5A9D52913E12Q37708277-41A0C0B6-8585-4020-A266-A6D8AA2867FEQ38009736-D9722094-9E14-4166-B010-12973AFB58C0Q38691764-4D50FCDC-1156-4D39-9415-B666C17B7A36Q46932015-7F8D8CBB-9A2C-4124-A33A-DFB998CF088EQ48898933-1F88DDC0-76F4-4418-A91F-E40ACF10F1D6Q51740698-52309058-5AD4-4329-8D05-FB9D4DF5E434Q54981644-0E814997-79F6-4292-ADEF-4AB9CF5D7E4E
P2860
Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@ast
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@en
type
label
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@ast
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@en
prefLabel
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@ast
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@en
P2093
P2860
P1476
Low dose dextromethorphan atte ...... nfiltration in the spinal cord
@en
P2093
Daniel J Daugherty
David E Pleasure
Florian Mayrhofer
Olga V Chechneva
Wenbin Deng
P2860
P356
10.1016/J.NBD.2011.06.004
P577
2011-06-24T00:00:00Z